David G. Mutch, MD, the Ira C. and Judith Gall Professor of Obstetrics and Gynecology at Washington University School of Medicine, has been elected chairman of the Foundation for Women’s Cancer board of directors.
Mutch also is director of the School of Medicine’s Division of Gynecologic Oncology, one of the largest divisions of its kind in the country, and vice chair of gynecology for the Department of Obstetrics and Gynecology. He is known for his research on gynecologic cancers, in particular cervical and endometrial cancers.
He has published about 300 papers on these subjects. Among his roles, he is the principal investigator of Washington University’s NRG Oncology group. NRG Oncology is a national nonprofit organization that conducts clinical research and broadly disseminates study results to help inform clinical decision-making and health-care policy. He also is the principal investigator of the Washington University Endometrial Specialized Program of Research Excellence (SPORE) grant.
The Foundation for Women’s Cancer is dedicated to expanding public awareness, education, research and training to improve the prevention, early detection and optimal treatment of gynecologic cancers. The national organization has provided more than $6 million in research funding since 1995. It is merging with the Foundation for the Society of Gynecologic Oncology but will retain the name the Foundation for Women’s Cancer.
“I am excited about overseeing the merger of these two great foundations that are dedicated to the advancement of the treatment of women’s cancers,” Mutch said.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.